Publications by authors named "Ahana Priyanka"

Importance: Schizophrenia is associated with increased age-related morbidity, mortality, and frailty, which are not entirely explained by behavioral factors. Prior studies using epigenetic clocks have suggested that schizophrenia is associated with accelerated aging, however these studies have primarily used unidimensional clocks that summarize aging as a single "biological age" score.

Objective: This meta-analysis uses multidimensional epigenetic clocks that split aging into multiple scores to analyze biological aging in schizophrenia.

View Article and Find Full Text PDF
Article Synopsis
  • Aging biomarkers can help researchers quickly assess the effects of aging interventions, bypassing the need for long-term studies, but their effectiveness as surrogate endpoints needs validation.
  • Epigenetic clocks, which are developed from DNA methylation patterns, show promise in this area and are being investigated for their responsiveness to various aging interventions.
  • The TranslAGE-Response database compiles data from numerous studies to identify patterns in how different interventions affect epigenetic clocks, revealing that some interventions have consistent effects while others do not, and highlighting the importance of considering study population and duration in these assessments.
View Article and Find Full Text PDF

The diagnostic and clinical overlap of early mild cognitive impairment (EMCI), mild cognitive impairment (MCI), late mild cognitive impairment (LMCI) and Alzheimer disease (AD) is a vital oncological issue in dementia disorder. This study is designed to examine Whole brain (WB), grey matter (GM) and Hippocampus (HC) morphological variation and identify the prominent biomarkers in MR brain images of demented subjects to understand the severity progression. Curve evolution based on shape constraint is carried out to segment the complex brain structure such as HC and GM.

View Article and Find Full Text PDF

Dementia is a degenerative irreversible disorder that globally causes a high socio-economic burden. The pathology progression of mild cognitive impairment (MCI) and Alzheimer diseases (AD) are correlated with each other. There is a need to examine the pathology variation to discriminate the disorder to provide appropriate treatment strategies.

View Article and Find Full Text PDF